Invenomic Capital Management’s Evertec EVTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.86M Buy
+210,799
New +$5.6M 0.35% 80
2025
Q4
Sell
-247,541
Closed -$8.36M 156
2025
Q3
$8.36M Buy
247,541
+132,063
+114% +$4.6M 0.4% 78
2025
Q2
$4.16M Sell
115,478
-175,030
-60% -$6.2M 0.24% 107
2025
Q1
$10.7M Buy
290,508
+14,529
+5% +$502K 0.54% 66
2024
Q4
$9.53M Buy
275,979
+90,057
+48% +$3.09M 0.45% 71
2024
Q3
$6.3M Sell
185,922
-36,010
-16% -$1.2M 0.35% 85
2024
Q2
$7.38M Buy
221,932
+161,618
+268% +$5.84M 0.36% 80
2024
Q1
$2.41M Buy
+60,314
New +$2.38M 0.13% 126

Other funds holding EVTC

Invenomic Capital Management's EVTC Position: Q2 2026 in Review

Invenomic Capital Management opened a new position in Evertec (EVTC) in Q2 2026: 210,799 shares worth $5.86M. The stake represents 0.35% of the portfolio and ranks #80 among its holdings. This is a return to the name: Invenomic Capital Management previously reported a position in EVTC as recently as Q3 2025.

Invenomic Capital Management first reported a position in EVTC in Q1 2024 and has held it in 8 quarters since. The position peaked at $10.7M in Q1 2025. 252 funds tracked by Wall St. Rank hold EVTC as of Q2 2026.

  • Invenomic Capital Management held 210,799 shares of Evertec worth $5.86M as of Q2 2026.
  • Evertec was a new Invenomic Capital Management position in Q2 2026.
  • Evertec made up 0.35% of Invenomic Capital Management's portfolio in Q2 2026, its #80 holding.
  • Invenomic Capital Management first reported a position in Evertec in Q1 2024 and has held it in 8 quarters since.
  • Invenomic Capital Management's Evertec position peaked at $10.7M in Q1 2025.
  • 252 funds tracked by Wall St. Rank held Evertec as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.